Cytoglia is dedicated to advancing therapies for patients suffering from debilitating and life-threatening rare diseases. Our work is driven by a clear purpose — to pursue cures where the need is urgent and options are limited. We are committed to building solutions that can make a meaningful difference in the lives of individuals and communities affected by these conditions.
Our company’s foundation is built on scientific focus, emerging leadership, and a long-term vision to expand therapeutic possibilities across several complex disease areas. While parts of our organization are under development, our mission remains constant: move toward impactful treatments with commitment and integrity.
Board of Directors
Dr. Madan Khurana
Qualification: PhD, National Dairy Research Institute, Karnal, Haryana
Experience: Assistant Professor, All India Institute of Medical Sciences (AIIMS), Delhi, India
Dr. Kiran Arise
Qualification: MBBS, PhD – Tulane University School of Medicine, New Orleans, USA
Experience:
• Medical Scientist, Actelion Pharmaceuticals, USA
• Medical Scientist, Alexion Pharmaceuticals, USA
Dr. Goutham Edula
Qualification: MBBS, MS – Loma Linda University, Los Angeles, USA
Experience:
• Medical Scientist, AstraZeneca Pharmaceuticals, Gothenburg, Sweden
Dr. Tilak Kada
MBBS (Gandhi Medical College)
MD (USA) IFMCP (USA)
Managing Director:
• Aptamed Multispeciality Clinic
• Aptamed Care Solutions Pvt Ltd
• Cytoglia Pvt Ltd
Experience & Certifications:
Functional Medicine/Geriatric Medicine/Family Medicine